Myocardial Infarction (MI)

Cardiovascular·MeSH: Myocardial Infarction

5 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Drug	Company
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
clopidogrel bi	DR REDDYS LABORATORIES LTD (RDY)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)

BioSniper tracks 5 drugs in development for Myocardial Infarction (MI) across 4 companies.

There are 1 clinical trial targeting Myocardial Infarction (MI) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.